Wealthstream Advisors, Inc. Dr Reddys Laboratories LTD Transaction History
Wealthstream Advisors, Inc.
- $625 Million
- Q3 2025
A detailed history of Wealthstream Advisors, Inc. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Wealthstream Advisors, Inc. holds 21,258 shares of RDY stock, worth $286,345. This represents 0.05% of its overall portfolio holdings.
Number of Shares
21,258
Previous 17,678
20.25%
Holding current value
$286,345
Previous $265,000
12.08%
% of portfolio
0.05%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding RDY
# of Institutions
257Shares Held
93.2MCall Options Held
0Put Options Held
0-
Robeco Institutional Asset Management B.V.13.1MShares$176 Million0.27% of portfolio
-
Royal Bank Of Canada Toronto, A69.96MShares$134 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.01MShares$121 Million0.19% of portfolio
-
Aikya Investment Management LTD London, X06.72MShares$90.5 Million26.28% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.4MShares$72.7 Million0.02% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.24B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...